Lumiphore

company

About

Lumiphore is an early stage research company developing proprietary lanthanide technology

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$598.88K
Industries
Biotechnology,Pharmaceutical
Number Of Employee
11 - 50
Operating Status
Active

Lumiphore is an early stage research company developing proprietary lanthanide technology for use in high-value applications and commercializing the technology by entering into market-specific alliances with corporate partners. The market for fluorescent reagents in biology is more than $1.0 billion and is growing 25% annually. Demand is greatest for reagents with sensitivity better than can be achieved with organic fluorescent molecules. It is generally recognized that lanthanide reporters show great promise for increased sensitivity but development of good lanthanides has lagged. Lumiphore’s proprietary, highly fluorescent and flexible lanthanide compounds are a new kind of ultrasensitive fluorophore that overcome the sensitivity limitation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$1.64M
Lumiphore has raised a total of $1.64M in funding over 2 rounds. Their latest funding was raised on Mar 25, 2014 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 25, 2014 Grant $899.31K 1 National Science Foundation Detail
Jun 15, 2012 Grant $149.49K 1 National Science Foundation Detail
Mar 26, 2012 Grant $598.88K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
3
1
Lumiphore is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant